Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 30:12:9363-9374.
doi: 10.2147/CMAR.S220976. eCollection 2020.

Benefits and Limitations of a Multidisciplinary Approach in Cancer Patient Management

Affiliations
Review

Benefits and Limitations of a Multidisciplinary Approach in Cancer Patient Management

Rossana Berardi et al. Cancer Manag Res. .

Abstract

Over the years, a growing body of literature has confirmed as beneficial the implementation of a multidisciplinary approach in the so-often-intricate scenario of cancer patients' management. Together with the consolidation of tumor-board experience in clinical practice, certain aspects have emerged as controversial and a source of current debate. In this systematic literature review, we focused our attention on the impact of multidisciplinary tumor boards, assessing benefits and limitations as a result of the dissemination of such approaches. On the bright side, adherence to clinical guidelines, treatment outcomes, and overall improvement in decision-making processes have been recognized as advantages. On the other side, our analysis highlights a few limitations that should be taken into account to optimize cancer patients' management. Of note, some issues, such as costs, legal responsibility, geographic barriers, and treatment delays, have yet to be resolved. In order partly to address this matter, software platforms and novel methods of computational analysis may provide the needed support. Therefore, the aim of our analysis was to describe the multidisciplinary approach in cancer care in terms of adherence to clinical guidelines, treatment outcomes, and overall improvement in decision-making processes through a systematic review of the literature.

Keywords: benefits; cancer patients; limitations; multidisciplinary; tumor board.

PubMed Disclaimer

Conflict of interest statement

Rossana Berardi reports grants from Astra Zeneca, Novartis, Merck Sharp & Dohme, and Lilly and personal fees from Otsuka, Boehringer, Merck Sharp & Dohme, and Lilly outside the submitted work. The other authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Multidisciplinary tumor board.
Figure 2
Figure 2
PRISMA.

References

    1. El Saghir NS, Keating NL, Carlson RW, Khoury KE, Fallowfield L. Tumor boards: optimizing the structure and improving efficiency of multidisciplinary management of patients with cancer worldwide. Am Soc Clin Oncol Educ Book. 2014;e461–6. doi:10.14694/EdBook_AM.2014.34.e461 - DOI - PubMed
    1. Blamey RW, Cataliotti L. EUSOMA accreditation of breast units. Eur J Cancer. 2006;42(10):1331–1337. doi:10.1016/j.ejca.2006.04.003 - DOI - PubMed
    1. National Cancer Institute. Defınition of tumor board review. Available from: http://www.cancer.gov/dictionary?cdrid=322893.
    1. Dickhoff C, Dahele M. The multidisciplinary lung cancer team meeting: increasing evidence that it should be considered a medical intervention in its own right. J Thorac Dis. 2019;11(3):311–314. doi:10.21037/jtd.2019.01.14 - DOI - PMC - PubMed
    1. Milligan Vlasto. Further reports on cases exhibited before the section at previous meetings, session 1921–1922. Proc R Soc Med. 1922;15:i.1–vii.1. - PMC - PubMed